{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T08:53:01Z","timestamp":1776588781357,"version":"3.51.2"},"reference-count":90,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.humimm.2022.04.011","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T21:29:53Z","timestamp":1653686993000},"page":"580-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential and challenges of placenta-derived decidua stromal cell therapy in inflammation-associated disorders"],"prefix":"10.1016","volume":"83","author":[{"given":"Elham","family":"Roshandel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mehravar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Dehghani Ghorbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Tabarraee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Hajifathali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2022.04.011_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trim.2018.01.002","article-title":"Mesenchymal stem cells therapy protects fetuses from resorption and induces Th2 type cytokines profile in abortion prone mouse model","volume":"47","author":"Farrokhi","year":"2018","journal-title":"Transpl. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2022.04.011_b0010","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s41423-021-00707-7","article-title":"Advances and challenges of mesenchymal stem cells for pregnancy-related diseases","volume":"18","author":"Li","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2022.04.011_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.humimm.2022.04.011_b0020","first-page":"1802","article-title":"Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: latest trends in isolation","volume":"13","author":"Munoz-Perez","year":"2021","journal-title":"Content Optim. Deliv. Avenues Pharmaceut."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1089\/scd.2004.13.436","article-title":"Mesenchymal stem cells: isolation and therapeutics","volume":"13","author":"Alhadlaq","year":"2004","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/stem.1934","article-title":"Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo","volume":"33","author":"Amarnath","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.humimm.2022.04.011_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-5-19","article-title":"Clinical applications of mesenchymal stem cells","volume":"5","author":"Wang","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.humimm.2022.04.011_b0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2017.11.010","article-title":"Human predecidual stromal cells have distinctive characteristics of pericytes: cell contractility, chemotactic activity, and expression of pericyte markers and angiogenic factors","volume":"61","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2018","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.humimm.2022.04.011_b0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1284-z","article-title":"Human predecidual stromal cells are mesenchymal stromal\/stem cells and have a therapeutic effect in an immune-based mouse model of recurrent spontaneous abortion","volume":"10","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.humimm.2022.04.011_b0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/rmb2.12088","article-title":"Decidualization of the human endometrium","volume":"17","author":"Okada","year":"2018","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.humimm.2022.04.011_b0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2022.04.011_b0060","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/stem.1314","article-title":"Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease","volume":"31","author":"Ringd\u00e9n","year":"2013","journal-title":"Stem cells"},{"issue":"19","key":"10.1016\/j.humimm.2022.04.011_b0065","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1089\/scd.2013.0079","article-title":"Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner","volume":"22","author":"Erkers","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","article-title":"Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells","volume":"18","author":"Najar","year":"2016","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.humimm.2022.04.011_b0075","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive factors secreted by human amniotic epithelial cells","volume":"46","author":"Li","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.humimm.2022.04.011_b0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3389\/fimmu.2019.01397","article-title":"Features of human decidual NK cells in healthy pregnancy and during viral infection","volume":"10","author":"Jabrane-Ferrat","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.04.011_b0085","first-page":"2792","article-title":"Human decidual stromal cells in early pregnancy induce functional re-programming of monocyte-derived dendritic cells via crosstalk between G-CSF and IL-1\u03b2","author":"Shao","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2022.04.011_b0090","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/1933719116632924","article-title":"Phenotypic and functional characterization of mesenchymal stem\/multipotent stromal cells from decidua parietalis of human term placenta","volume":"23","author":"Abumaree","year":"2016","journal-title":"Reprod. Sci."},{"issue":"7","key":"10.1016\/j.humimm.2022.04.011_b0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","article-title":"Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta","volume":"22","author":"in 't Anker","year":"2004","journal-title":"Stem cells"},{"key":"10.1016\/j.humimm.2022.04.011_b0100","first-page":"223","article-title":"Growth kinetic comparison of human mesenchymal stem cells from bone marrow, adipose tissue and decidua","volume":"24","author":"Kazemi","year":"2020","journal-title":"Med. Sci."},{"key":"10.1016\/j.humimm.2022.04.011_b0105","doi-asserted-by":"crossref","unstructured":"O.V. Semenov, S. Koestenbauer, M. Riegel, N. Zech, R. Zimmermann, A.H. Zisch et al., Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am. J. Obstetr. Gynecol. 202 (2010), p. 193. e191-193. e113.","DOI":"10.1016\/j.ajog.2009.10.869"},{"key":"10.1016\/j.humimm.2022.04.011_b0110","first-page":"51","article-title":"Phenotypic and functional responses of human decidua basalis mesenchymal stem\/stromal cells to lipopolysaccharide of gram-negative bacteria","volume":"14","author":"Alshareef","year":"2021","journal-title":"Stem Cells Cloning: Adv. Appl."},{"key":"10.1016\/j.humimm.2022.04.011_b0115","doi-asserted-by":"crossref","unstructured":"F.D. Lublin, J.D. Bowen, J. Huddlestone, M. Kremenchutzky, A. Carpenter, J.R. Corboy et al., Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult. Scle. Related Disord., 3 (2014), p. 696-704.","DOI":"10.1016\/j.msard.2014.08.002"},{"issue":"5","key":"10.1016\/j.humimm.2022.04.011_b0120","doi-asserted-by":"crossref","first-page":"e12990","DOI":"10.1111\/petr.12990","article-title":"Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease","volume":"21","author":"Gustafsson","year":"2017","journal-title":"Pediatr. Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/jhrs.JHRS_30_19","article-title":"Female unexplained infertility: a disease with imbalanced adaptive immunity","volume":"12","author":"Ehsani","year":"2019","journal-title":"J. Hum. Reprod. Sci."},{"issue":"6086","key":"10.1016\/j.humimm.2022.04.011_b0130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1220030","article-title":"Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface","volume":"336","author":"Nancy","year":"2012","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.humimm.2022.04.011_b0135","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1096\/fj.201700399RR","article-title":"Neutrophil extracellular traps are critical for pregnancy loss in sphingosine kinase\u2013deficient mice on 129Sv\/C57BL\/6 background","volume":"31","author":"Mizugishi1","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.humimm.2022.04.011_b0140","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jcyt.2015.09.001","article-title":"Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo","volume":"17","author":"Sadeghi","year":"2015","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/scd.2014.0265","article-title":"Treatment of severe chronic graft-versus-host disease with decidual stromal cells and tracing with 111Indium radiolabeling","volume":"24","author":"Erkers","year":"2015","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/sctm.17-0167","article-title":"Placenta-derived decidua stromal cells for treatment of severe acute graft-versus-host disease","volume":"7","author":"Ringden","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.humimm.2022.04.011_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00795","article-title":"Safety and side effects of using placenta-derived decidual stromal cells for graft-versus-host disease and hemorrhagic cystitis","volume":"8","author":"Baygan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.04.011_b0160","unstructured":"O. Ringd\u00e9n, M. Solders, T. Erkers, S. Nava, P. Molld\u00e9n, M. Hultcrantz et al., Successful reversal of acute lung injury using placenta-derived decidual stromal cells. J Stem Cell Res Ther, 4 (2014), p. 2157-7633.1000244,"},{"issue":"6","key":"10.1016\/j.humimm.2022.04.011_b0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2022.04.011_b0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-472X(00)00677-9","article-title":"Acute graft-vs-host disease: pathobiology and management","volume":"29","author":"Goker","year":"2001","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.humimm.2022.04.011_b0175","series-title":"11th Annual meeting of the EBMT","first-page":"128","article-title":"The Biology of Chronic Graft-Versus-Host Disease. 11th Annual meeting of the EBMT","author":"Deeg","year":"1985"},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0180","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/bmt.2015.261","article-title":"A risk-adapted approach to acute GVHD treatment: are we there yet?","volume":"51","author":"Holtan","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.humimm.2022.04.011_b0185","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"issue":"9624","key":"10.1016\/j.humimm.2022.04.011_b0190","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.humimm.2022.04.011_b0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/bmt.2008.316","article-title":"Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium","volume":"43","author":"von Bonin","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.humimm.2022.04.011_b0200","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbmt.2010.03.017","article-title":"Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population","volume":"16","author":"Lucchini","year":"2010","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"7","key":"10.1016\/j.humimm.2022.04.011_b0205","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","article-title":"Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease","volume":"15","author":"Kebriaei","year":"2009","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000485735","article-title":"Placenta-derived decidua stromal cells for hemorrhagic cystitis after stem cell transplantation","volume":"139","author":"Aronsson-Kurttila","year":"2018","journal-title":"Acta Haematol."},{"issue":"10","key":"10.1016\/j.humimm.2022.04.011_b0215","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.bbmt.2019.05.034","article-title":"Long-term follow-up of a pilot study using placenta-derived Decidua Stromal Cells for severe acute graft-versus-host disease","volume":"25","author":"Sadeghi","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.humimm.2022.04.011_b0220","first-page":"2439","article-title":"Mesenchymal stromal cells in pediatric hematopoietic cell transplantation a review and a pilot study in children treated with decidua stromal cells for acute graft-versus-host disease","author":"Ringd\u00e9n","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0225","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.humimm.2022.04.011_b0230","doi-asserted-by":"crossref","first-page":"103789","DOI":"10.1016\/j.ebiom.2021.103789","article-title":"Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.humimm.2022.04.011_b0235","article-title":"Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"6","author":"Shi","year":"2021","journal-title":"Signal Transd. Targeted Ther."},{"issue":"22","key":"10.1016\/j.humimm.2022.04.011_b0240","doi-asserted-by":"crossref","first-page":"10554","DOI":"10.1111\/jcmm.16986","article-title":"Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells","volume":"25","author":"Sadeghi","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.humimm.2022.04.011_b0245","first-page":"1","article-title":"Unexplained infertility, the controversial matter in management of infertile couples","volume":"16","author":"Sadeghi","year":"2015","journal-title":"J. Reprod. Infertility"},{"key":"10.1016\/j.humimm.2022.04.011_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/762541","article-title":"Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone","volume":"2012","author":"Haller-Kikkatalo","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.humimm.2022.04.011_b0255","series-title":"Yen and Jaffe's Reproductive Endocrinology","first-page":"556","article-title":"Female infertility","author":"Barbieri","year":"2019"},{"issue":"1","key":"10.1016\/j.humimm.2022.04.011_b0260","article-title":"3D-cultured human placenta-derived mesenchymal stem cell spheroids enhance ovary function by inducing folliculogenesis","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.humimm.2022.04.011_b0265","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/1933719117732156","article-title":"Restoring ovarian function with human placenta-derived mesenchymal stem cells in autoimmune-induced premature ovarian failure mice mediated by Treg cells and associated cytokines","volume":"25","author":"Yin","year":"2018","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.humimm.2022.04.011_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-02002-0","article-title":"Microenvironmental changes induced by placenta-derived mesenchymal stem cells restore ovarian function in ovariectomized rats via activation of the PI3K-FOXO3 pathway","volume":"11","author":"Choi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.humimm.2022.04.011_b0275","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/antiox9070591","article-title":"Placenta-derived mesenchymal stem cells restore the ovary function in an ovariectomized rat model via an antioxidant effect","volume":"9","author":"Seok","year":"2020","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.humimm.2022.04.011_b0280","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02275-z","article-title":"Human placental mesenchymal stem cells ameliorate chemotherapy-induced damage in the testis by reducing apoptosis\/oxidative stress and promoting autophagy","volume":"12","author":"Lu","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.humimm.2022.04.011_b0285","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.7556\/jaoa.2015.124","article-title":"Effects of stem cell treatment in human patients with Peyronie disease","volume":"115","author":"Levy","year":"2015","journal-title":"J. Osteop. Med."},{"key":"10.1016\/j.humimm.2022.04.011_b0290","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.7556\/jaoa.2016.007","article-title":"Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells","volume":"116","author":"Levy","year":"2016","journal-title":"J. Osteop. Med."},{"key":"10.1016\/j.humimm.2022.04.011_b0295","doi-asserted-by":"crossref","unstructured":"T.L. Spitzer, A. Rojas, Z. Zelenko, L. Aghajanova, D.W. Erikson, F. Barragan et al., Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biol. Reprod., 86 (2012), p. 58, 51-16","DOI":"10.1095\/biolreprod.111.095885"},{"issue":"7","key":"10.1016\/j.humimm.2022.04.011_b0300","doi-asserted-by":"crossref","first-page":"109138","DOI":"10.1016\/j.celrep.2021.109138","article-title":"Pluripotent stem cell-derived endometrial stromal fibroblasts in a cyclic, hormone-responsive, coculture model of human decidua","volume":"35","author":"Cheung","year":"2021","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.humimm.2022.04.011_b0305","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000323973","article-title":"p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells","volume":"26","author":"Tian","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.humimm.2022.04.011_b0310","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/scd.2011.0441","article-title":"A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys","volume":"21","author":"Wang","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.humimm.2022.04.011_b0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157488810790442796","article-title":"Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique","volume":"5","author":"Centeno","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.humimm.2022.04.011_b0320","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3892\/mmr.2016.5537","article-title":"Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells","volume":"14","author":"Tang","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0325","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12015-014-9514-3","article-title":"Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells","volume":"10","author":"Lin","year":"2014","journal-title":"Stem Cell Rev. Rep."},{"issue":"6","key":"10.1016\/j.humimm.2022.04.011_b0330","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/jcb.24073","article-title":"Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro","volume":"113","author":"Gauthaman","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.humimm.2022.04.011_b0335","first-page":"2506","article-title":"Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer","volume":"6","author":"Zhu","year":"2013","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.humimm.2022.04.011_b0340","doi-asserted-by":"crossref","first-page":"103326","DOI":"10.1016\/j.jri.2021.103326","article-title":"Decidualization modulates the mesenchymal stromal\/stem cell and pericyte characteristics of human decidual stromal cells. Effects on antigen expression, chemotactic activity on monocytes and antitumoral activity","volume":"145","author":"Ruiz-Maga\u00f1a","year":"2021","journal-title":"J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0345","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/bio.2017.0057","article-title":"The clinical applications of endometrial mesenchymal stem cells","volume":"16","author":"Zuo","year":"2018","journal-title":"Biopreserv. Biobanking"},{"issue":"10","key":"10.1016\/j.humimm.2022.04.011_b0350","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ng1631","article-title":"Genomic alterations in cultured human embryonic stem cells","volume":"37","author":"Maitra","year":"2005","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.1615","article-title":"High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity","volume":"28","author":"N\u00e4rv\u00e4","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.humimm.2022.04.011_b0360","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt0404-381","article-title":"Karyotype of human ES cells during extended culture","volume":"22","author":"Buzzard","year":"2004","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.humimm.2022.04.011_b0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nbt922","article-title":"Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells","volume":"22","author":"Draper","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.humimm.2022.04.011_b0370","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/molehr\/gah051","article-title":"Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation","volume":"10","author":"Inzunza","year":"2004","journal-title":"Mol. Hum. Reprod."},{"issue":"2","key":"10.1016\/j.humimm.2022.04.011_b0375","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nbt1285","article-title":"Adaptation to culture of human embryonic stem cells and oncogenesis in vivo","volume":"25","author":"Baker","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.humimm.2022.04.011_b0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.stem.2010.12.003","article-title":"Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture","volume":"8","author":"Laurent","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.humimm.2022.04.011_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9628536","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2019","author":"Lukomska","year":"2019","journal-title":"Stem Cells Int."},{"issue":"20","key":"10.1016\/j.humimm.2022.04.011_b0390","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.yexcr.2011.09.008","article-title":"Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro","volume":"317","author":"Ren","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.humimm.2022.04.011_b0395","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.yexcr.2010.02.016","article-title":"Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells","volume":"316","author":"Garcia","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.humimm.2022.04.011_b0400","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1158\/0008-5472.CAN-10-2451","article-title":"Retraction: Spontaneous human adult stem cell transformation","volume":"70","author":"De la Fuente","year":"2010","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.humimm.2022.04.011_b0405","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","article-title":"Spontaneous human adult stem cell transformation","volume":"65","author":"Rubio","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2022.04.011_b0410","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1158\/0008-5472.CAN-10-1305","article-title":"Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track\u2013letter","volume":"70","author":"Torsvik","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.humimm.2022.04.011_b0415","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.humimm.2022.04.011_b0420","first-page":"50","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placenta decidua","volume":"28","author":"Moll","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.humimm.2022.04.011_b0425","doi-asserted-by":"crossref","unstructured":"M.A. Dobrovolskaia, S.E. McNeil: Understanding the Correlation between in vitro and in vivo Immunotoxicity Tests for Engineered Nanomaterials. Handbook of immunological Properties of Engineered Nanomaterials: Volume 1: Key Considerations for Nanoparticle Characterization Prior to Immunotoxicity Studies, World Scientific, 2016, p 317-344.","DOI":"10.1142\/9789813140431_0012"},{"issue":"6","key":"10.1016\/j.humimm.2022.04.011_b0430","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.humimm.2022.04.011_b0435","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jnc.13516","article-title":"The next step in translational research: lessons learned from the first preclinical randomized controlled trial","volume":"139","author":"Llovera","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.humimm.2022.04.011_b0440","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/ijms21030727","article-title":"Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent","volume":"21","author":"Joo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2022.04.011_b0445","first-page":"692","article-title":"The unique immunomodulatory properties of MSC-derived exosomes in organ transplantation","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.humimm.2022.04.011_b0450","doi-asserted-by":"crossref","first-page":"2002596","DOI":"10.1002\/advs.202002596","article-title":"Exosomes for wound healing: purification optimization and identification of bioactive components","volume":"7","author":"Hettich","year":"2020","journal-title":"Adv. Sci."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:01Z","timestamp":1759319701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":90,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0198885922000921"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.04.011","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential and challenges of placenta-derived decidua stromal cell therapy in inflammation-associated disorders","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}